In vivo dissection of the mouse tyrosine catabolic pathway with CRISPR-Cas9 identifies modifier genes affecting hereditary tyrosinemia type 1
Jean-François Rivest, Sophie Carter, Claudia Goupil, Denis Cyr, Roth‐Visal Ung, Dorothée Bouron Dal Soglio, Fabrice Mac‐Way, Paula J. Waters, Massimiliano Paganelli, Yannick Doyon
The paper uses CRISPR-Cas9 in mice to identify modifier genes that affect the severity of tyrosinemia type 1 by editing enzymes in the tyrosine catabolic pathway.
bioRxiv · Sep 29, 2023 · PreprintGenetics